The effects of cysteamine on dopamine-mediated behaviors: Evidence for dopamine-somatostatin interactions in the striatum

Mathew T. Martin-Iverson, James M. Radke, Steven R. Vincent

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The effects of prior treatment with cysteamine, a drug which appears to deplete selectively the neuropeptide somatostatin, on apomorphine-induced stereotypy and amphetamine-induced locomotor activity and conditioned place preferences were investigated. Twelve hours following systemic cysteamine injections apomorphine-induced stereotypy was attenuated and striatal somatostatin levels were reduced by half. Systemic cysteamine also decreased the motor stimulant effects of amphetamine, without influencing the rewarding properties as determined by the conditioned place preference procedure. Direct injections of cysteamine into the nucleus accumbens also decreased the locomotor response to amphetamine, and produced a local reduction in somatostatin levels in the accumbens. Cysteamine did not appear to alter monoamine turnover in the striatum after either systemic or intra-accumbens injections. These results suggest that somatostatin in the nucleus accumbens and caudate-putamen modulates the motor, but not the reinforcing properties of dopaminergic drugs, possibly via an action postsynaptic to dopamine-releasing terminals. Furthermore, it is evident from these results that cysteamine is an important tool with which to study the central actions of somatostatin.

Original languageEnglish
Pages (from-to)1707-1714
Number of pages8
JournalPharmacology, Biochemistry and Behavior
Volume24
Issue number6
DOIs
Publication statusPublished - 1 Jan 1986
Externally publishedYes

Fingerprint

Cysteamine
Somatostatin
Dopamine
Amphetamine
Apomorphine
Nucleus Accumbens
Injections
Corpus Striatum
Dopamine Agents
Putamen
Direct injection
Locomotion
Neuropeptides
Pharmaceutical Preparations

Cite this

@article{c622e4ea27964f0ca744a4682d7c9836,
title = "The effects of cysteamine on dopamine-mediated behaviors: Evidence for dopamine-somatostatin interactions in the striatum",
abstract = "The effects of prior treatment with cysteamine, a drug which appears to deplete selectively the neuropeptide somatostatin, on apomorphine-induced stereotypy and amphetamine-induced locomotor activity and conditioned place preferences were investigated. Twelve hours following systemic cysteamine injections apomorphine-induced stereotypy was attenuated and striatal somatostatin levels were reduced by half. Systemic cysteamine also decreased the motor stimulant effects of amphetamine, without influencing the rewarding properties as determined by the conditioned place preference procedure. Direct injections of cysteamine into the nucleus accumbens also decreased the locomotor response to amphetamine, and produced a local reduction in somatostatin levels in the accumbens. Cysteamine did not appear to alter monoamine turnover in the striatum after either systemic or intra-accumbens injections. These results suggest that somatostatin in the nucleus accumbens and caudate-putamen modulates the motor, but not the reinforcing properties of dopaminergic drugs, possibly via an action postsynaptic to dopamine-releasing terminals. Furthermore, it is evident from these results that cysteamine is an important tool with which to study the central actions of somatostatin.",
keywords = "Cysteamine, Dopamine agonists, Locomotor activity, Place preference, Somatostatin, Stereotpypy",
author = "Martin-Iverson, {Mathew T.} and Radke, {James M.} and Vincent, {Steven R.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0091-3057(86)90509-5",
language = "English",
volume = "24",
pages = "1707--1714",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier",
number = "6",

}

The effects of cysteamine on dopamine-mediated behaviors : Evidence for dopamine-somatostatin interactions in the striatum. / Martin-Iverson, Mathew T.; Radke, James M.; Vincent, Steven R.

In: Pharmacology, Biochemistry and Behavior, Vol. 24, No. 6, 01.01.1986, p. 1707-1714.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effects of cysteamine on dopamine-mediated behaviors

T2 - Evidence for dopamine-somatostatin interactions in the striatum

AU - Martin-Iverson, Mathew T.

AU - Radke, James M.

AU - Vincent, Steven R.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The effects of prior treatment with cysteamine, a drug which appears to deplete selectively the neuropeptide somatostatin, on apomorphine-induced stereotypy and amphetamine-induced locomotor activity and conditioned place preferences were investigated. Twelve hours following systemic cysteamine injections apomorphine-induced stereotypy was attenuated and striatal somatostatin levels were reduced by half. Systemic cysteamine also decreased the motor stimulant effects of amphetamine, without influencing the rewarding properties as determined by the conditioned place preference procedure. Direct injections of cysteamine into the nucleus accumbens also decreased the locomotor response to amphetamine, and produced a local reduction in somatostatin levels in the accumbens. Cysteamine did not appear to alter monoamine turnover in the striatum after either systemic or intra-accumbens injections. These results suggest that somatostatin in the nucleus accumbens and caudate-putamen modulates the motor, but not the reinforcing properties of dopaminergic drugs, possibly via an action postsynaptic to dopamine-releasing terminals. Furthermore, it is evident from these results that cysteamine is an important tool with which to study the central actions of somatostatin.

AB - The effects of prior treatment with cysteamine, a drug which appears to deplete selectively the neuropeptide somatostatin, on apomorphine-induced stereotypy and amphetamine-induced locomotor activity and conditioned place preferences were investigated. Twelve hours following systemic cysteamine injections apomorphine-induced stereotypy was attenuated and striatal somatostatin levels were reduced by half. Systemic cysteamine also decreased the motor stimulant effects of amphetamine, without influencing the rewarding properties as determined by the conditioned place preference procedure. Direct injections of cysteamine into the nucleus accumbens also decreased the locomotor response to amphetamine, and produced a local reduction in somatostatin levels in the accumbens. Cysteamine did not appear to alter monoamine turnover in the striatum after either systemic or intra-accumbens injections. These results suggest that somatostatin in the nucleus accumbens and caudate-putamen modulates the motor, but not the reinforcing properties of dopaminergic drugs, possibly via an action postsynaptic to dopamine-releasing terminals. Furthermore, it is evident from these results that cysteamine is an important tool with which to study the central actions of somatostatin.

KW - Cysteamine

KW - Dopamine agonists

KW - Locomotor activity

KW - Place preference

KW - Somatostatin

KW - Stereotpypy

UR - http://www.scopus.com/inward/record.url?scp=0022457942&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(86)90509-5

DO - 10.1016/0091-3057(86)90509-5

M3 - Article

VL - 24

SP - 1707

EP - 1714

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 6

ER -